OC90
Otoconin-90
Also known as: OC90_HUMAN, PLA2L
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02509
- Gene
- OC90
- Ensembl
- ENSG00000253117
- Chromosome
- 8
- Canonical length
- 477 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
Predicted to enable calcium ion binding activity; calcium-dependent phospholipase A2 activity; and phospholipid binding activity. Predicted to be involved in otolith mineralization; phosphatidylcholine metabolic process; and phosphatidylglycerol metabolic process. Predicted to be located in extracellular region. Predicted to be active in extracellular matrix. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
477 residues, UniProt reviewed canonical sequence.
>Q02509|OC90
1 MIAFLLTSVL MIPHAGGHPL DTPHLPQELP PGLPNNINIT FFSGMFKNVE SVAEIFDCLG
61 PHFTWLQAVF TNFPVLIQFV NGMKCVAGLC PRDFEDYGCT CRFEMEGLPV DESDSCCFQH
121 RRCYEEAAEM DCLQDPAKLS TEVNCVSKKI ICESKDNCEH LLCTCDKAAI ECLARSSLNS
181 SLNLLDTSFC LAQTPETTIK EDLTTLLPRV VPVEPTDTSL TALSGEEAGH DQEGVGAARA
241 TSPPGSAEIV ATRVTAKIVT LVPAGIKSLG LAVSSVENDP EETTEKACDR FTFLHLGSGD
301 NMQVMPQLGE MLFCLTSRCP EEFESYGCYC GQEGRGEPRD DLDRCCLSHH CCLEQVRRLG
361 CLLERLPWSP VVCVDHTPKC GGQSLCEKLL CACDQTAAEC MTSASFNQSL KSPSRLGCPG
421 QPAACEDSLH PVPAAPTLGS SSEEDSEEDP PQEDLGRAKR FLRKSLGPLG IGPLHGRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OC90 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 0.3 nTPM
Expression across tissuesHPA
Tissue
- midbrain: 0.3 nTPM
- cerebral cortex: 0.1 nTPM
- choroid plexus: 0.1 nTPM
- hypothalamus: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
Single-cell type
- other brain neurons: 0.9 nCPM
- brain inhibitory neurons: 0.4 nCPM
- brain excitatory neurons: 0.2 nCPM
- oligodendrocyte progenitor cells: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 0.4 nTPM
- thalamus: 0.3 nTPM
- cerebral cortex: 0.2 nTPM
- hypothalamus: 0.2 nTPM
- hippocampal formation: 0.1 nTPM
- pons: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.01
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- arachidonate secretion
- lipid catabolic process
- otolith mineralization
- phosphatidylcholine metabolic process
- phosphatidylglycerol metabolic process
Molecular functions
- calcium ion binding
- calcium-dependent phospholipase A2 activity
- phospholipid binding
- structural molecule activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OC90 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OC90 as an antibody target. Whether an autoantibody or antibody against OC90 could matter depends on whether native OC90 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OC90 is annotated as secreted, so native OC90 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label OC90 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...